Application of Cervical Elastography in Obstetrics
- Conditions
- Cervical Elastography
- Interventions
- Device: Samsung's E-cervix technology
- Registration Number
- NCT03902587
- Lead Sponsor
- NYU Langone Health
- Brief Summary
The purpose of this study is to develop cervical elastography nomograms using Samsung's novel technology "E-cervix" and determine its ability to predict preterm birth.
During each sonogram in which cervical lengths are measured, 5 additional cervical indices will be collected using Samsung's E-cervix technology. Each index will then be separated based on characteristics to create a nomogram for singletons, twins, and those with interventions already in place (i.e. cerclage and/or progesterone) at the time of their E-cervix assessment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 1000
- Women who present for early screening or level II ultrasound, aged 18 to 50 years, provides written Informed consent and is willing to comply with protocol requirements, and obtained cervical length and measurements using the E-cervix software/hardware
- >50 years old
- prior cervical surgical procedures (i.e. LEEP procedure, cold knife cone biopsy)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Cervical Elastography Samsung's E-cervix technology During each sonogram in which cervical lengths are measured, 5 additional cervical indices will be collected using Samsung's E-cervix technology. Each index will then be separated based on characteristics to create a nomogram for singletons, twins, and those with interventions already in place (i.e. cerclage and/or progesterone) at the time of their E-cervix assessment.
- Primary Outcome Measures
Name Time Method Number of preterm Births 24 Months
- Secondary Outcome Measures
Name Time Method E-cervix indices 18 Weeks, 19 Weeks, 20 Weeks, 21 Weeks, 22 Weeks Pearson or Spearman correlation coefficients will be calculated to determine the association between the cervical length and each of the e-cervix parameters at the baseline assessment at 18-22 weeks.
Trial Locations
- Locations (1)
NYU Winthrop Hospital
🇺🇸Mineola, New York, United States